Clinical Trial Update: Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of Desonide Gel 0.05% in younger and older subjects with atopic dermatitis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Desonide Gel 0.05% (desonide)

Snippet

Sponsor: Wake Forest University | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED | Results posted: 2017-03-28